180 Life Sciences Corp. Gains 79.37%

Fri, Dec 30, 2022 at 07:06 PM

180 Life Sciences Corp. (ATNF:NASDAQ) soared at $3.39, a gain of 79.4%. On Fri, Dec 30, 2022, ATNF:NASDAQ touched a New 2-Week High of $3.39. The stock got featured on our News Catalysts scanner on Thu, Dec 29, 2022 at 08:38 AM in the 'LETTER TO STOCKHOLDERS' category. From Fri, Dec 16, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

About 180 Life Sciences Corp. (ATNF:NASDAQ)

180 Life Sciences Corp is a clinical-stage biotechnology company.

Top 10 Gainers:

Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
Palisade Bio Inc. (PALI:NASDAQ), 61.49%
F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%